
CStone Pharmaceuticals
Bio-pharmaceutical company.
Market cap
$1.8b
Enterprise value
$1.8b
Share price
HKD10.98 2616.HK
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
* | N/A | HKD467m | Post IPO Equity |
Total Funding | 000k |

GIC(exited)

YunFeng Capital(exited)

Taikang Life Insurance(exited)

Sequoia(exited)

6 Dimensions Capital(exited)

CITIC PE(exited)

ARCH Venture Partners(exited)

Boyu Capital(exited)

King Star Capital(exited)

Hillhouse Capital(exited)

Oriza Seed Capital(exited)

WuXi Healthcare Ventures(exited)

HongShan(exited)

Terra Magnum Capital Partners(exited)
CNY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | (77 %) | 98 % | (4 %) | (12 %) | (39 %) | 395 % | (29 %) |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (751 %) | (164 %) | (103 %) | (8 %) | (96 %) | 88 % | 17 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (788 %) | (188 %) | (79 %) | (22 %) | (107 %) | 74 % | 13 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 535 % | 128 % | 114 % | 33 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.